Director - Investor Relations

ABOUT ARCHIMED With offices in Europe, the US and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare. Our mix of operational, medical, scientific and financial expertise positions us as both a strategic and financial partner to healthcare businesses. Priority areas include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools and Biologic Services, MedTech and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.ARCHIMED manages $11 billion across its funds, including the largest healthcare-only private equity fund raised by a European-based GP. MED I, MED II and MED Platform I are all top-decile performers for their vintage according to Preqin data. Since inception, ARCHIMED has been a committed impact investor, both directly and through its EURÊKA Foundation.THE TEAM An international team (French, British, German, Polish, Canadian, US, Japanese) with complementary backgrounds across investment, medical, scientific, strategic and operational disciplines.Alumni of INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, École des Ponts ParisTech, ESSEC, Imperial College and Dartmouth, among others.Professional backgrounds spanning Private Equity (3i, Siparex, USS Ltd, Barings, Capiton, Partners Group), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC) and Industry (Biotronik, Cerba, pharmacy and veterinary).THE ROLE Reporting to the Head of Investor Relations, the Director of Investor Relations will play a leadership role in the strategic direction and execution of ARCHIMED's global capital formation and LP engagement efforts. This is a senior, high-visibility position with direct exposure to the firm's Partners and leadership, significant LP-facing responsibility and ownership of material components of the IR function.FUNDRAISING LEADERSHIP Partner with the Head of Investor Relations and firm leadership to shape fundraising strategy across flagship funds, co-investment vehicles and GP-led secondaries, including market positioning, investor segmentation and campaign sequencing.Own the end-to-end production of institutional-quality fundraising materials (PPM, DDQ, pitch decks, VDR, track record analytics) and manage the legal and structural workstreams alongside external counsel and service providers.Serve as a senior external voice for the firm. Represent ARCHIMED at investor conferences, industry events and LP meetings, and articulate the firm's strategy, performance and impact thesis with credibility and precision.Build, deepen and independently manage a portfolio of global LP relationships across sovereign wealth funds, pension plans, insurance companies, endowments, foundations, fund of funds, family offices and consultants. Identify and cultivate new pools of capital to support the firm's growth trajectory.Lead select roadshows, drive pipeline development and hold direct accountability for LP commitments and conversion metrics.IR FUNCTION OWNERSHIP Oversee the operation of the firm's IR program, including quarterly and annual fund and co-investment reporting in partnership with Finance, Impact and Investment Teams.Own LP servicing including capital calls, distributions, information requests, secondary transfers and bespoke LP workstreams, and establish the standards and playbooks that scale with AUM growth.Lead the planning and delivery of the Investor AGM and other flagship LP events in close coordination with the Communications team.Mentor and develop junior IR team members and contribute to the build-out of the function as the platform grows.CO-INVESTMENTS, GP-LED SECONDARIES AND STRATEGIC VEHICLES Drive the firm's co-investment program with existing LPs and the broader institutional community, working alongside deal teams to syndicate opportunities efficiently and on favorable terms.Contribute to the strategic evolution of ARCHIMED's fund platform by structuring and leading GP-led secondaries, continuation vehicles and other bespoke capital solutions where appropriate.RequirementsSenior IR professional with approximately 10 to 15 years of relevant experience in investor relations, fundraising or LP coverage within private equity or alternative asset management. Prior experience raising institutional capital at scale is essential.Established network of institutional LP relationships across multiple geographies, with a demonstrated ability to manage complex relationships independently and convert dialogue into commitments.Strong financial acumen. Fluency with fund structuring, LPA terms, performance metrics (gross and net IRR, TVPI, DPI, PME), portfolio analytics and the quantitative diligence expected by sophisticated LPs.Deep knowledge of market practice, fund terms, fee structures and the competitive landscape in healthcare and broader PE.Exceptional communicator. Able to translate complex investment theses, industry dynamics and deal structures into clear, factual narratives for the most sophisticated audiences.Commercial mindset and entrepreneurial orientation. Capable of identifying new market opportunities, new channels and new product formats to expand AUM.Proven ability to operate in a fast-paced environment, manage competing priorities and deliver under pressure without sacrificing quality.Advanced Excel and PowerPoint skills. Fluency with IR CRM systems (Dynamo, Backstop, Altvia or similar) preferred.Higher education degree in finance, economics or business administration. CFA or MBA a plus.Embodies ARCHIMED's cultural values of inclusion, meritocracy, partnership, accountability, client focus and trust.BenefitsHealth, Vision and Dental premiums covered 100% by ARCHIMED Carried InterestAugust Summer Shutdown Winter Shutdown (Christmas - New Years) Monthly Commute Stipend more

ABOUT ARCHIMED

With offices in Europe, the US and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare. Our mix of operational, medical, scientific and financial expertise positions us as both a strategic and financial partner to healthcare businesses. Priority areas include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools and Biologic Services, MedTech and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.

ARCHIMED manages $11 billion across its funds, including the largest healthcare-only private equity fund raised by a European-based GP. MED I, MED II and MED Platform I are all top-decile performers for their vintage according to Preqin data. Since inception, ARCHIMED has been a committed impact investor, both directly and through its EURÊKA Foundation.

THE TEAM

An international team (French, British, German, Polish, Canadian, US, Japanese) with complementary backgrounds across investment, medical, scientific, strategic and operational disciplines.

Alumni of INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, École des Ponts ParisTech, ESSEC, Imperial College and Dartmouth, among others.

Professional backgrounds spanning Private Equity (3i, Siparex, USS Ltd, Barings, Capiton, Partners Group), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC) and Industry (Biotronik, Cerba, pharmacy and veterinary).

THE ROLE

Reporting to the Head of Investor Relations, the Director of Investor Relations will play a leadership role in the strategic direction and execution of ARCHIMED's global capital formation and LP engagement efforts. This is a senior, high-visibility position with direct exposure to the firm's Partners and leadership, significant LP-facing responsibility and ownership of material components of the IR function.

FUNDRAISING LEADERSHIP

Partner with the Head of Investor Relations and firm leadership to shape fundraising strategy across flagship funds, co-investment vehicles and GP-led secondaries, including market positioning, investor segmentation and campaign sequencing.

Own the end-to-end production of institutional-quality fundraising materials (PPM, DDQ, pitch decks, VDR, track record analytics) and manage the legal and structural workstreams alongside external counsel and service providers.

Serve as a senior external voice for the firm. Represent ARCHIMED at investor conferences, industry events and LP meetings, and articulate the firm's strategy, performance and impact thesis with credibility and precision.

Build, deepen and independently manage a portfolio of global LP relationships across sovereign wealth funds, pension plans, insurance companies, endowments, foundations, fund of funds, family offices and consultants. Identify and cultivate new pools of capital to support the firm's growth trajectory.

Lead select roadshows, drive pipeline development and hold direct accountability for LP commitments and conversion metrics.

IR FUNCTION OWNERSHIP

Oversee the operation of the firm's IR program, including quarterly and annual fund and co-investment reporting in partnership with Finance, Impact and Investment Teams.

Own LP servicing including capital calls, distributions, information requests, secondary transfers and bespoke LP workstreams, and establish the standards and playbooks that scale with AUM growth.

Lead the planning and delivery of the Investor AGM and other flagship LP events in close coordination with the Communications team.

Mentor and develop junior IR team members and contribute to the build-out of the function as the platform grows.

CO-INVESTMENTS, GP-LED SECONDARIES AND STRATEGIC VEHICLES

Drive the firm's co-investment program with existing LPs and the broader institutional community, working alongside deal teams to syndicate opportunities efficiently and on favorable terms.

Contribute to the strategic evolution of ARCHIMED's fund platform by structuring and leading GP-led secondaries, continuation vehicles and other bespoke capital solutions where appropriate.

Requirements

• Senior IR professional with approximately 10 to 15 years of relevant experience in investor relations, fundraising or LP coverage within private equity or alternative asset management. Prior experience raising institutional capital at scale is essential.
• Established network of institutional LP relationships across multiple geographies, with a demonstrated ability to manage complex relationships independently and convert dialogue into commitments.
• Strong financial acumen. Fluency with fund structuring, LPA terms, performance metrics (gross and net IRR, TVPI, DPI, PME), portfolio analytics and the quantitative diligence expected by sophisticated LPs.
• Deep knowledge of market practice, fund terms, fee structures and the competitive landscape in healthcare and broader PE.
• Exceptional communicator. Able to translate complex investment theses, industry dynamics and deal structures into clear, factual narratives for the most sophisticated audiences.
• Commercial mindset and entrepreneurial orientation. Capable of identifying new market opportunities, new channels and new product formats to expand AUM.
• Proven ability to operate in a fast-paced environment, manage competing priorities and deliver under pressure without sacrificing quality.
• Advanced Excel and PowerPoint skills. Fluency with IR CRM systems (Dynamo, Backstop, Altvia or similar) preferred.
• Higher education degree in finance, economics or business administration. CFA or MBA a plus.
• Embodies ARCHIMED's cultural values of inclusion, meritocracy, partnership, accountability, client focus and trust.

Benefits

• Health, Vision and Dental premiums covered 100% by ARCHIMED
• Carried Interest
• August Summer Shutdown
• Winter Shutdown (Christmas - New Years)
• Monthly Commute Stipend
• more

With offices in the US, Europe and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to North American and European healthcare businesses.Prioritized areas of focus include Healthcare IT, MedTech, Pharma Services, Life Science Tools & Biologic Services, Biopharma Products, In Vitro Diagnostics, Consumer Health. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.Over the last twenty years, ARCHIMED's leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over €50 billion of combined value. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact Investor, both directly and through its EURÊKA Foundation.The Team An international team (British, French, German, Italian, Polish...) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary)

With offices in the US, Europe and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to North American and European healthcare businesses.

Prioritized areas of focus include Healthcare IT, MedTech, Pharma Services, Life Science Tools & Biologic Services, Biopharma Products, In Vitro Diagnostics, Consumer Health. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.

Over the last twenty years, ARCHIMED's leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over €50 billion of combined value. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact Investor, both directly and through its EURÊKA Foundation.

The Team

• An international team (British, French, German, Italian, Polish...) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors
• Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc
• Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary)